Clinical trial
Pragmatic Randomized Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis
NCT04340895 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pragmatic Randomized Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis
- Lead sponsor
- Ferring Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 14, 2019
- Completion date
- October 20, 2023
- Enrollment
- 250 (actual)
- Sites
- 42
Conditions
As the registry lists them; a condition with its own page is linked.
mild-to-moderate ulcerative colitis